dexamethasone,lenalidomide,carfilzomib
amgen
['mmsm', 'atlas']
in abstract discussion, great slide summarizing financial toxicity (and time toxicity!) of krd maintenance in atlas versus r maintenance. pros must be included and considered. #mmsm #asco22 
Heme/onc fellow. #lymsm & #mmsm patient-reported outcomes researcher. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. ??????